Specialty Ingredients To Grow With Shifting Trends In Emerging Markets
This article was originally published in The Rose Sheet
Executive Summary
For the 2012-2017 period, sales volume growth for specialty ingredients will reach 7% or more on a compounded annual basis in markets such as China, India and South Asia as demand shifts away from cheaper commodity products, Kline predicts, drawing from interviews with industry members and data captured in its Personal Care Ingredients Database.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.